Journal Guide

Aging Cell is a bi-monthly peer-reviewed, open access journal that aims to publish the highest quality, innovative research addressing fundamental issues in the biology of aging. For publication in Aging Cell, the work must provide a major new contribution to the understanding of aging and be of general interest to the community. Aging Cell seeks to cover all areas of geroscience, highlighting research that uncovers mechanistic aspects of the aging process, as well as the links between aging and age-related disease. Observations of novel aging processes without substantial mechanistic insight will be considered, but should be of especially high impact for the field. Topics including, but not limited to, nutrient-responsive signaling pathways, neuronal and endocrine signaling pathways, tissue interactions, genetic and epigenetic regulation and integrity, proteostasis, circadian rhythms, ROS and mitochondria, cellular senescence, stem cells, progerias and interventions that affect aging are encouraged. All experimental approaches, including plant models, are welcome. Papers that focus on the pathogenesis of a specific age-related pathology are also of interest, but should offer new insights into the fundamental links between aging and disease.

Aging Medicine is a peer reviewed open access journal that aims to facilitate international collaboration and exchange of comprehensive and cutting-edge information on basic, translational, and applied clinical research as well as epidemiological and translational studies in geriatrics.

Agribusiness: An International Journal publishes research that improves our understanding of how food systems work, how they are evolving, and how public and/or private actions affect the performance of the global agro-industrial complex. The journal focuses on the application of economic analysis to the organization and performance of firms and markets in industrial food systems. Subject matter areas include supply and demand analysis, industrial organization analysis, price and trade analysis, marketing, finance, and public policy analysis. International, cross-country comparative, and within-country studies are welcome. To facilitate research the journal's Forum section, on an intermittent basis, offers commentary and reports on business policy issues.

Agricultural Economics aims to disseminate the most important research results and policy analyses in our discipline, from all regions of the world. Topical coverage ranges from consumption and nutrition to land use and the environment, at every scale of analysis from households to markets and the macro-economy. Applicable methodologies include econometric estimation and statistical hypothesis testing, optimization and simulation models, descriptive reviews and policy analyses. We particularly encourage submission of empirical work that can be replicated and tested by others.

Agronomy Journal is the flagship journal of ASA. Articles convey original research in agriculture, natural resources, soil science, crop science, agroclimatology, agronomic modeling, production agriculture, and instrumentation.

Aims Alcoholism: Clinical & Experimental Research's aims are:

Alimentary Pharmacology & Therapeutics is an international journal of gastroenterology and hepatology. The journal accepts original papers and systematic reviews concerned with clinical gastroenterology, hepatology and endoscopy. AP&T is particularly interested in therapies and diagnostics, including all aspects of translation from bench to bedside: identification of novel therapeutic targets, epidemiology, clinical trials, drug safety and meta-analyses.

The aim of the journal is to promote and maintain contact between basic and clinical allergy and immunology. Allergy is an international journal with contributors and readers in all countries. Articles are accepted purely on the basis of quality. The journal publishes original articles, reviews, position papers, and short communications (AllergyNet). Original articles of special interest are accompanied by editorial comments. Correspondence to recently published work is also considered.

The expectation for published papers will be to translate fundamental knowledge about the neurobiology of the disease into practical reports that describe both the conceptual and methodological aspects of the submitted scientific inquiry. Published topics will explore the development of biomarkers, surrogate markers, and conceptual/methodological challenges. Publication priority will be given to papers that 1) describe putative surrogate markers that accurately track disease progression, 2) biomarkers that fulfill international regulatory requirements, 3) reports from large, well-characterized population-based cohorts that comprise the heterogeneity and diversity of asymptomatic individuals and 4) algorithmic development that considers multi-marker arrays (e.g., integrated-omics, genetics, biofluids, imaging, etc.) and advanced computational analytics and technologies.

Given the growing number of specialized manuscripts in the field of Alzheimer's and dementia research, DADM will provide an expanded platform to provide a) rapid communication and publication that facilitate cross-fertilization of ideas, b) integrating and translating knowledge across disciplines; disseminating basic and clinical information necessary for optimal translation of research into practical applications and interventions, c) increase knowledge in diverse areas of studies with potentials/implications for practical application related to early detection and/or interventions, d) formulating crucial experiments necessary for the rigorous testing of theories or their predictions, and e) identifying promising new directions of research and providing the impetus or the scientific foundation for new initiatives on interventions.

The mission of Alzheimer's & Dementia: Journal of the Alzheimer's Association is to bridge the knowledge gaps across a wide range of bench-to-bedside investigation. The journal publishes the results of studies in: behavior, biochemistry, genetics, molecular biology, pharmacology, physiology, protein chemistry, neurology, neuropathology, psychiatry, geriatrics, neuropsychology, epidemiology, sociology, health services research, health economics, political science and public policy. Content emphasizes interdisciplinary investigations, integrative/translational articles, related to: etiology, risk factors, early detection, disease modifying interventions, prevention of dementia and applications of new technologies in health services. The journal publishes • comprehensive reviews; • research articles; • information on clinical trials; • short reports;• in-depth perspectives/open-peer commentaries; • theoretical and/or translational papers that attempt integrate knowledge across discipline;• history & politics of science/brief biographies and, • abstracts of papers presented at international meetings. Negative results, particularly clinical trials, are published as short communications.The ultimate objective is to create a novel forum for: • rapid communication of new findings, ideas or perspectives; • disseminating knowledge, across the spectrum of basic to clinical studies, necessary for optimal translation of research findings into practical applications/interventions; • integrating knowledge across disciplines; • increase knowledge in diverse disciplines to promote early detection/diagnosis and/or interventions; • formulating new theories and/or strategies for the rigorous testing of theories or their predictions; • identifying promising new directions of research and, • providing the scientific impetus for new initiatives; or public policies concerning research on prevention and new models of health services.Alzheimer's & Dementia is indexed/abstracted in Index Medicus/MEDLINE, Scopus, Science Citation Index Expanded (SciSearch®), Current Contents®/Clinical Medicine, Neuroscience Citation Index®, and Journal Citation Reports/Science Edition.

Alzheimer's & Dementia: Translational Research & Clinical Interventions (TRCI) is an open access, peer-reviewed, journal from the Alzheimer's Association® that covers translational research and clinical therapeutics for Alzheimer's disease, dementia and other age-related conditions affecting cognition, memory, and behavior. The journal will provide a rapid method for communication among a multidisciplinary clinical research audience involving the range of therapeutic interventions (e.g., drugs, biologicals, devices, and psychotherapeutic, psychosocial, and non-pharmacological modalities) from preclinical development to late stage trials and health technology assessment.

The focus is original, feature length research articles, systematic reviews, metaanalyses, brief reports, narrative reviews, commentaries, letters, perspectives, and research news that advance the prevention and treatment of Alzheimer's disease, dementia, and cognitive impairment. The journal will publish on topics related to medicine, geriatrics, neuroscience, neurology, psychiatry, clinical psychology, bioinformatics, and health policy as they apply to preclinical and clinical therapeutics. It will focus on discovery, therapeutic development, clinical pharmacology, preclinical studies, and the application of neuropsychology, clinical ratings, clinical trials methods, neuroimaging, biomarkers, clinical research informatics, and other interdisciplinary approaches to clinical therapeutics and outcomes.

Given the growing number of specialized manuscripts in the field of Alzheimer's and dementia research, TRCI provides an expanded platform for the publication of clinical translational research. TRCI encourages the submission of manuscripts that describe preclinical research with a potential for clinical application, research from early human experimentation (experimental medicine) that may advance clinical treatment and prevention of Alzheimer pathology, neurodegeneration, and cognitive impairment.

Like Alzheimer's & Dementia, TRCI will publish manuscripts describing public health research with the potential for application for disease prevention or clinical therapeutics that bridges the laboratory and clinical settings, and laboratory studies of novel therapeutic interventions and new treatment paradigms. Expanding on the growing number of submissions to Alzheimer's & Dementia, TRCI will provide a rapid communication vehicle for manuscripts that focus on translation and clinical research methods, procedures, protocols, analytical approaches and regulatory science.

BenchCouncil Transactions on Benchmarks, Standards and Evaluations (TBench) publishes position articles that open new research areas; research articles that address new problems; methodologies; tools; survey articles that build up comprehensive knowledge; and comment articles that argue published articles. Submissions should deal with benchmarks, standards and evaluation research areas.

The American Journal of Physical Anthropology (AJPA) is the official journal of the American Association of Physical Anthropologists. The Journal is published monthly in three quarterly volumes. In addition, two supplements appear on an annual basis, the Yearbook of Physical Anthropology, which publishes major review articles, and the Annual Meeting Issue, containing the Scientific Program of the Annual Meeting of the American Association of Physical Anthropologists and abstracts of posters and podium presentations. The Yearbook of Physical Anthropology has its own editor, appointed by the Association, and is handled independently of the AJPA. As measured by impact factor, the AJPA is among the top journals listed in the anthropology category by the Social Science Citation Index. The reputation of the AJPA as the leading publication in physical anthropology is built on its nearly century-long record of publishing high quality scientific articles in a wide range of topics. The Editor-in-Chief welcomes for consideration manuscripts that contribute to an understanding of the evolution of members of the order Primates, with particular emphasis on human biological evolution and variation. Within this framework, the AJPA publishes in established areas, including human biology and non-human primate behavior, and also seeks submissions in new and developing fronts that contribute to the growth of the science and increased understanding of human and non-human primate evolution. The AJPA publishes scientific articles without page charges, as well as invited commentaries, book reviews, and short communications dealing mostly with methodological and technical issues. Manuscripts submitted elsewhere will not be considered for publication. The Editor-in-Chief seeks input on cover design from the AJPA readership. Authors are encouraged to submit illustrative materials for inclusion on the cover. Research manuscripts should be sent to the Office of the Editor-in-Chief. Invited book reviews should be sent to the Associate Editor for Book Reviews. The Office of the Editor-in-Chief is located at the Johns Hopkins University, Baltimore. The AJPA is a peer-reviewed scientific publication. The Editor-in-Chief works with the assistance of Associate Editors appointed by the Executive Committee of the Association, and seeks advice of reviewers recommended by the Associate Editors. The review process is anonymous.